All the cases below involved extensive work with experts in the fields of epidemiology, pharmacology, toxicology, neurology, neurosurgery, neuropsychology, oncology, radiology, cardiology, pathology, life care planning, physical therapy, biostatistics, vascular surgery, radiology and interventional radiology, and economics. These cases also entailed the review and analysis of medical and scientific studies and documents obtained in discovery.
- In re Zofran Products Liability Litigation – In this case, the firm represented clients alleging birth defects were associated with Zofran exposure. Steve served on the court-appointed Plaintiffs Steering Committee before the Honorable Judge F. Dennis Saylor IV of the United States District Court for the District of Massachusetts. Steve also served as co-chair of the Science and Expert Committee in this multi-district litigation.
- Boston Youth Tobacco Litigation – Steve is currently involved in representing clients who have developed smoking-related disease from starting to smoke in their teens, becoming addicted to nicotine and smoking for decades. One of those cases resulted in a jury verdict of $200 Million, including punitive damages.
- In re Phenylpropanolamine (PPA) Products Liability Litigation – In the PPA litigation (decongestants associated with hemorrhagic stroke - 2000-2006), Steve was principally responsible for the MDL general causation Daubert briefing and general causation expert witness work. He took multiple depositions of defense liability witnesses and MDL causation experts in the fields of epidemiology and stroke neurology.
- In re Hormone Replacement Therapy Litigation – In HRT (2007-2012), Steve contributed to common benefit work regarding Daubert issues, safer alternative science development, recruitment of case specific causation, cell biology and epidemiology experts, and was primarily responsible for negotiating an aggregate settlement for clients who were exposed to estrogen without a progestogen. For individual HRT cases (2007- 2012), he handled all causation witnesses in two federal court trials (one settled post defense verdict; one plaintiffs’ verdict resulting in a $4 million compensatory and punitive damages award. He also recruited experts in oncology, pathology, cell biology, radiology, and epidemiology, and took or defended over 80 depositions.
- In re Fresenius Granuflo/Naturalyte Dialysate Products Liability Litigation – In this case, Steve served as a member of the Daubert committee and conducted significant work finding and preparing expert witnesses (in the areas of epidemiology, general, and specific causation), drafting multiple Daubert briefs, and arguing Daubert motions before the Honorable Judge Woodlock of the United States District Court for the District of Massachusetts.
- Bard IVC Filter Litigation – This case involves the representation of clients with defective IVC filters. Steve served on the Plaintiffs’ Steering Committee in the multi-district litigation, and represented individual clients who suffered injuries from defective IVC filters.
- Essure Products Liability Litigation – In this case, Hausfeld represented clients with claims against Bayer Healthcare for injuries caused by the Essure® System for Permanent Birth Control.
- Talcum Powder Products Litigation – In this litigation, the firm is representing clients who allege that their long term use of talcum powder products led to their development of ovarian cancer. Steve serves on the Science and Expert Committee.
- Steve serves on the Plaintiffs’ Steering Committee and the Expert and Science Committee in the Zantac multi-district litigation.
- Steve serves on the Plaintiffs’ Steering Committee and the Expert and Science Committee in the TDF multi-district litigation.
- In re Diet Drugs – Steve represented clients in this litigation alleging that diet pills were causing heart and lung injuries.
- Steve has also represented clients with defective Cox-2 inhibitor pain medications associated with heart attacks; clients who were prescribed Yaz birth control pills associated with clotting injuries, and clients alleging Paxil-related birth defect cases.
